Lahdenne P - Search Results

1

[Special features of biological drug therapy in children].

Aalto K, Leinonen S, Kolho KL, Lahdenne P. Aalto K, et al. Among authors: lahdenne p. Duodecim. 2016;132(4):377-82. Duodecim. 2016. PMID: 27017790 Review. Finnish.

2

Nerve growth factor in serum of children with systemic lupus erythematosus is correlated with disease activity.

Aalto K, Korhonen L, Lahdenne P, Pelkonen P, Lindholm D. Aalto K, et al. Among authors: lahdenne p. Cytokine. 2002 Nov 7;20(3):136-9. doi: 10.1006/cyto.2002.1991. Cytokine. 2002. PMID: 12453472

3

Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis.

Valta H, Lahdenne P, Jalanko H, Aalto K, Mäkitie O. Valta H, et al. Among authors: lahdenne p. J Rheumatol. 2007 Apr;34(4):831-6. Epub 2007 Feb 15. J Rheumatol. 2007. PMID: 17309121

4

Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.

Tynjälä P, Kotaniemi K, Lindahl P, Latva K, Aalto K, Honkanen V, Lahdenne P. Tynjälä P, et al. Among authors: lahdenne p. Rheumatology (Oxford). 2008 Mar;47(3):339-44. doi: 10.1093/rheumatology/kem356. Epub 2008 Jan 31. Rheumatology (Oxford). 2008. PMID: 18238789

5

Prevention of acute adverse events related to infliximab infusions in pediatric patients.

Lahdenne P, Wikström AM, Aalto K, Kolho KL. Lahdenne P, et al. Arthritis Care Res (Hoboken). 2010 Jun;62(6):785-90. doi: 10.1002/acr.20246. Arthritis Care Res (Hoboken). 2010. PMID: 20535789 Free article.

6

Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis.

Aalto K, Honkanen V, Lahdenne P. Aalto K, et al. Among authors: lahdenne p. Clin Rheumatol. 2011 Jan;30(1):115-9. doi: 10.1007/s10067-010-1571-7. Epub 2010 Sep 30. Clin Rheumatol. 2011. PMID: 20882311

7

Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis.

Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M; Nordic Study Group of Pediatric Rheumatology. Nordal E, et al. Among authors: lahdenne p. Arthritis Rheum. 2011 Sep;63(9):2809-18. doi: 10.1002/art.30426. Arthritis Rheum. 2011. PMID: 21560116 Free article.

8

Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P. Tynjälä P, et al. Among authors: lahdenne p. Ann Rheum Dis. 2011 Sep;70(9):1605-12. doi: 10.1136/ard.2010.143347. Epub 2011 May 28. Ann Rheum Dis. 2011. PMID: 21623000 Clinical Trial.

9

Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting.

Nordal EB, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Peltoniemi S, Straume B, Rygg M. Nordal EB, et al. Among authors: lahdenne p. Ann Rheum Dis. 2012 Jul;71(7):1122-7. doi: 10.1136/annrheumdis-2011-200237. Epub 2012 Jan 17. Ann Rheum Dis. 2012. PMID: 22258487

10

[Medical treatment of juvenile idiopathic arthritis].

Kröger L, Vähäsalo P, Tynjälä P, Aalto K, Säilä H, Malin M, Putto-Laurila A, Lahdenne P. Kröger L, et al. Among authors: lahdenne p. Duodecim. 2012;128(5):477-86. Duodecim. 2012. PMID: 22486063 Review. Finnish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters